2025 -- H 6422 | |
======== | |
LC003061 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2025 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES | |
| |
Introduced By: Representative Paul M. Santucci | |
Date Introduced: June 17, 2025 | |
Referred To: House Corporations | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Chapter 27-18 of the General Laws entitled "Accident and Sickness Insurance |
2 | Policies" is hereby amended by adding thereto the following section: |
3 | 27-18-95. Buprenorphine. |
4 | Every individual or group health insurance contract, plan, or policy that provides |
5 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
6 | on or after January 1, 2026, shall provide coverage for at least one type of buprenorphine for each |
7 | form of administration. There shall be no copayment required and no deductible shall need to be |
8 | met by the contract, plan, or policy, every twelve (12) month plan year. A deductible may be applied |
9 | to health plans that are paired with a federally qualified health savings account pursuant to 26 U.S.C |
10 | § 223. Nothing in this section would prohibit a health plan from implementing this benefit prior to |
11 | January 1. 2026 |
12 | SECTION 2. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service |
13 | Corporations" is hereby amended by adding thereto the following section: |
14 | 27-19-87. Buprenorphine. |
15 | Every individual or group health insurance contract, plan, or policy that provides |
16 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
17 | on or after January 1, 2026, shall provide coverage for at least one type of buprenorphine for each |
18 | form of administration. There shall be no copayment required and no deductible shall need to be |
19 | met by the contract, plan, or policy, every twelve (12) month plan year. A deductible may be applied |
| |
1 | to health plans that are paired with a federally qualified health savings account pursuant to 26 U.S.C |
2 | § 223. Nothing in this section would prohibit a health plan from implementing this benefit prior to |
3 | January 1. 2026. |
4 | SECTION 3. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service |
5 | Corporations" is hereby amended by adding thereto the following section: |
6 | 27-20-83. Buprenorphine. |
7 | Every individual or group health insurance contract, plan, or policy that provides |
8 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
9 | on or after January 1, 2026, shall provide coverage for at least one type of buprenorphine for each |
10 | form of administration. There shall be no copayment required and no deductible shall need to be |
11 | met by the contract, plan, or policy, every twelve (12) month plan year. A deductible may be applied |
12 | to health plans that are paired with a federally qualified health savings account pursuant to 26 U.S.C |
13 | § 223. Nothing in this section would prohibit a health plan from implementing this benefit prior to |
14 | January 1. 2026. |
15 | SECTION 4. Chapter 27-41 of the General Laws entitled "Health Maintenance |
16 | Organizations" is hereby amended by adding thereto the following section: |
17 | 27-41-100. Buprenorphine. |
18 | Every individual or group health insurance contract, plan, or policy that provides |
19 | prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state |
20 | on or after January 1, 2026, shall provide coverage for at least one type of buprenorphine for each |
21 | form of administration. There shall be no copayment required and no deductible shall need to be |
22 | met by the contract, plan, or policy, every twelve (12) month plan year. A deductible may be applied |
23 | to health plans that are paired with a federally qualified health savings account pursuant to 26 U.S.C |
24 | § 223. Nothing in this section would prohibit a health plan from implementing this benefit prior to |
25 | January 1. 2026. |
26 | SECTION 5. This act shall take effect on January 1, 2026. |
======== | |
LC003061 | |
======== | |
| LC003061 - Page 2 of 3 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES | |
*** | |
1 | This act would require every individual or group health insurance contract, plan, or policy |
2 | that provides prescription coverage and that is delivered, issued for delivery, prescribed, or renewed |
3 | in this state on or after January 1, 2026, to provide coverage for at least one type of buprenorphine |
4 | for each form of administration. |
5 | This act would take effect on January 1, 2026. |
======== | |
LC003061 | |
======== | |
| LC003061 - Page 3 of 3 |